Explain How New ORAL Semaglutide Stacks Up for Weight Loss

February 2026

Patients are asking about Rx semaglutide tablets (Wegovy), the first ORAL GLP-1 agonist FDA approved for obesity and overweight.

It’s the same med in injectable Wegovy for weight loss...or injectable Ozempic or oral Rybelsus for type 2 diabetes.

But oral Wegovy is taken DAILY...versus weekly with the injection.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote